整合孟德尔随机化和多转录组分析,揭示调节性T细胞介导的游离胆固醇与胃癌的遗传关联风险。

IF 2.8 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Fanyu Peng, Haitao Liu, Yesong Guo, Jing Wen, Yizhi Ge, Yanhong Luo
{"title":"整合孟德尔随机化和多转录组分析,揭示调节性T细胞介导的游离胆固醇与胃癌的遗传关联风险。","authors":"Fanyu Peng, Haitao Liu, Yesong Guo, Jing Wen, Yizhi Ge, Yanhong Luo","doi":"10.1007/s12672-025-02739-1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Evidence from observational studies suggests an association between free cholesterol and gastric cancer. Immune cells play a crucial role in the tumor microenvironment of gastric cancer, and free cholesterol can influence immune cells in various ways, thereby impacting gastric cancer. The mechanisms by which free cholesterol regulates and activates the immune response to exert antitumor effects, as well as the causal relationship between free cholesterol and gastric cancer, remain unclear.</p><p><strong>Methods: </strong>We employed a two-sample Mendelian randomization (MR) approach to investigate the causal relationship between 233 metabolites and gastric cancer. Additionally, we validated our findings using data from GWAS databases of similar traits. Using publicly available genetic data, we analyzed the causal relationship between 731 types of immune cells and gastric cancer. Furthermore, we explored the mediating role of regulatory T cells in the causal relationship between free cholesterol and gastric cancer through multivariable Mendelian randomization. Finally, we validated our results using data from the TCGA database and single-cell sequencing data.</p><p><strong>Findings: </strong>We found a causal relationship between free cholesterol levels and gastric cancer (odds ratio [OR] = 0.89, confidence interval [CI] = 0.81-0.98, P < 0.05). We also observed a causal relationship between free cholesterol levels and regulatory T cells (odds ratio [OR] = 0.86, confidence interval [CI] = 0.75-0.98, P < 0.05), and between regulatory T cells and gastric cancer (odds ratio [OR] = 1.04, confidence interval [CI] = 1.01-1.07, P < 0.05). Additionally, our multivariable Mendelian randomization analysis indicated that regulatory T cells mediate the causal relationship between free cholesterol levels and gastric cancer. Furthermore, through single-cell sequencing analysis and data analysis from the TCGA database, we found that the expression of the free cholesterol uptake protein LDLR is negatively correlated with Treg infiltration, which further influences the occurrence and development of gastric cancer.</p><p><strong>Interpretation: </strong>Our analysis indicates a causal relationship between free cholesterol levels and gastric cancer, with regulatory T cells acting as mediators. Modulating free cholesterol levels to influence regulatory T cells may offer new insights and prospects for the prevention and treatment of gastric cancer.</p>","PeriodicalId":11148,"journal":{"name":"Discover. Oncology","volume":"16 1","pages":"864"},"PeriodicalIF":2.8000,"publicationDate":"2025-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12098249/pdf/","citationCount":"0","resultStr":"{\"title\":\"Integrating Mendelian randomization and multi-transcriptomic analyses to unveil the genetic association risk of regulatory T cell-mediated free cholesterol and gastric cancer.\",\"authors\":\"Fanyu Peng, Haitao Liu, Yesong Guo, Jing Wen, Yizhi Ge, Yanhong Luo\",\"doi\":\"10.1007/s12672-025-02739-1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Evidence from observational studies suggests an association between free cholesterol and gastric cancer. Immune cells play a crucial role in the tumor microenvironment of gastric cancer, and free cholesterol can influence immune cells in various ways, thereby impacting gastric cancer. The mechanisms by which free cholesterol regulates and activates the immune response to exert antitumor effects, as well as the causal relationship between free cholesterol and gastric cancer, remain unclear.</p><p><strong>Methods: </strong>We employed a two-sample Mendelian randomization (MR) approach to investigate the causal relationship between 233 metabolites and gastric cancer. Additionally, we validated our findings using data from GWAS databases of similar traits. Using publicly available genetic data, we analyzed the causal relationship between 731 types of immune cells and gastric cancer. Furthermore, we explored the mediating role of regulatory T cells in the causal relationship between free cholesterol and gastric cancer through multivariable Mendelian randomization. Finally, we validated our results using data from the TCGA database and single-cell sequencing data.</p><p><strong>Findings: </strong>We found a causal relationship between free cholesterol levels and gastric cancer (odds ratio [OR] = 0.89, confidence interval [CI] = 0.81-0.98, P < 0.05). We also observed a causal relationship between free cholesterol levels and regulatory T cells (odds ratio [OR] = 0.86, confidence interval [CI] = 0.75-0.98, P < 0.05), and between regulatory T cells and gastric cancer (odds ratio [OR] = 1.04, confidence interval [CI] = 1.01-1.07, P < 0.05). Additionally, our multivariable Mendelian randomization analysis indicated that regulatory T cells mediate the causal relationship between free cholesterol levels and gastric cancer. Furthermore, through single-cell sequencing analysis and data analysis from the TCGA database, we found that the expression of the free cholesterol uptake protein LDLR is negatively correlated with Treg infiltration, which further influences the occurrence and development of gastric cancer.</p><p><strong>Interpretation: </strong>Our analysis indicates a causal relationship between free cholesterol levels and gastric cancer, with regulatory T cells acting as mediators. Modulating free cholesterol levels to influence regulatory T cells may offer new insights and prospects for the prevention and treatment of gastric cancer.</p>\",\"PeriodicalId\":11148,\"journal\":{\"name\":\"Discover. Oncology\",\"volume\":\"16 1\",\"pages\":\"864\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-05-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12098249/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Discover. Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s12672-025-02739-1\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Discover. Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12672-025-02739-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

摘要

背景:来自观察性研究的证据表明游离胆固醇与胃癌之间存在关联。免疫细胞在胃癌的肿瘤微环境中起着至关重要的作用,游离胆固醇可以通过多种方式影响免疫细胞,从而影响胃癌。游离胆固醇调节和激活免疫反应发挥抗肿瘤作用的机制以及游离胆固醇与胃癌的因果关系尚不清楚。方法:采用双样本孟德尔随机化(MR)方法研究233种代谢物与胃癌的因果关系。此外,我们使用GWAS数据库中相似性状的数据验证了我们的发现。利用公开的遗传数据,我们分析了731种免疫细胞与胃癌之间的因果关系。此外,我们通过多变量孟德尔随机化方法探讨了调节性T细胞在游离胆固醇与胃癌因果关系中的介导作用。最后,我们使用TCGA数据库和单细胞测序数据验证了我们的结果。研究结果:我们发现游离胆固醇水平与胃癌之间存在因果关系(优势比[OR] = 0.89,置信区间[CI] = 0.81-0.98, P)。解释:我们的分析表明游离胆固醇水平与胃癌之间存在因果关系,其中调节性T细胞起中介作用。调节游离胆固醇水平影响调节性T细胞可能为胃癌的预防和治疗提供新的见解和前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Integrating Mendelian randomization and multi-transcriptomic analyses to unveil the genetic association risk of regulatory T cell-mediated free cholesterol and gastric cancer.

Background: Evidence from observational studies suggests an association between free cholesterol and gastric cancer. Immune cells play a crucial role in the tumor microenvironment of gastric cancer, and free cholesterol can influence immune cells in various ways, thereby impacting gastric cancer. The mechanisms by which free cholesterol regulates and activates the immune response to exert antitumor effects, as well as the causal relationship between free cholesterol and gastric cancer, remain unclear.

Methods: We employed a two-sample Mendelian randomization (MR) approach to investigate the causal relationship between 233 metabolites and gastric cancer. Additionally, we validated our findings using data from GWAS databases of similar traits. Using publicly available genetic data, we analyzed the causal relationship between 731 types of immune cells and gastric cancer. Furthermore, we explored the mediating role of regulatory T cells in the causal relationship between free cholesterol and gastric cancer through multivariable Mendelian randomization. Finally, we validated our results using data from the TCGA database and single-cell sequencing data.

Findings: We found a causal relationship between free cholesterol levels and gastric cancer (odds ratio [OR] = 0.89, confidence interval [CI] = 0.81-0.98, P < 0.05). We also observed a causal relationship between free cholesterol levels and regulatory T cells (odds ratio [OR] = 0.86, confidence interval [CI] = 0.75-0.98, P < 0.05), and between regulatory T cells and gastric cancer (odds ratio [OR] = 1.04, confidence interval [CI] = 1.01-1.07, P < 0.05). Additionally, our multivariable Mendelian randomization analysis indicated that regulatory T cells mediate the causal relationship between free cholesterol levels and gastric cancer. Furthermore, through single-cell sequencing analysis and data analysis from the TCGA database, we found that the expression of the free cholesterol uptake protein LDLR is negatively correlated with Treg infiltration, which further influences the occurrence and development of gastric cancer.

Interpretation: Our analysis indicates a causal relationship between free cholesterol levels and gastric cancer, with regulatory T cells acting as mediators. Modulating free cholesterol levels to influence regulatory T cells may offer new insights and prospects for the prevention and treatment of gastric cancer.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Discover. Oncology
Discover. Oncology Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
2.40
自引率
9.10%
发文量
122
审稿时长
5 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信